Previous Close | 8.42 |
Open | 8.35 |
Bid | 8.32 x 100 |
Ask | 8.39 x 100 |
Day's Range | 8.23 - 8.70 |
52 Week Range | 5.01 - 12.75 |
Volume | |
Avg. Volume | 714,407 |
Market Cap | 572.71M |
Beta (5Y Monthly) | 2.48 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.32 |
Earnings Date | May 06, 2024 - May 10, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 41.25 |
LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will present at the 23rd Annual Needham Virtual Healthcare Conference at 8:00am ET on April 9, 2024. A live audio webcast of the presentation will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible
In this article, we will be taking a look at the 20 most depressed countries in Asia. If you do not want to learn about the Asian depression market, head straight to the 5 Most Depressed Countries in Asia. Overview of the Global and Asian Depression Market The global depression market is a significant sector […]
David Norton Assumes Role of Interim Board Chair while the Company Runs a Global Search for a New ChairLONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that Board Chair and co-founder George Goldsmith and fellow co-founder Ekaterina Malievskaia have resigned their seats on the company’s board of directors, effective March 29, 2